Terms ending in 2028
Otsuka Pharmaceutical Co., Ltd.
Every in-force patent on Otsuka Pharmaceutical Co., Ltd.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,943,623 | Pharmaceutical Composition Comprising 2,3-Dihydro-6-Nitroimidazo [2,1-b] Oxazole Derivatives In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US D699,119 | Packaging Bag In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US RE46,792 | Oxazole Compound and Pharmaceutical Composition In force · Low confidence | Otsuka Pharmaceutical Co., Ltd. | In force | Low confidence | |
| US 8,552,188 | Epoxy Compound and Method for Manufacturing the Same In force · Medium confidence | Otsuka Pharmaceutical Co., Ltd. | In force | Medium confidence | |
| US D705,080 | Container for Drinking Jelly In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 10,681,930 | Equol-Containing Extract, Method for Production Thereof, Method for Extraction of Equol, and Equol-Containing Food In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US D709,377 | Container In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 8,273,735 | Process for Preparing Benzazepine Compounds or Salts Thereof In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 10,238,604 | Controlled Activation Ingestible Identifier In force · Medium confidence | Otsuka Pharmaceutical Co., Ltd. | In force | Medium confidence | |
| US D713,854 | Display Screen Portion Having a Graphical User Interface for Patient Monitoring In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| 9 more term ends in 2028 · Pro | |||||
10 of 19 patents shown. Soonest term end first, then patent number.
Pro members see all 19, including 5 expiring within the 18 months from Nov 22, 2026.
16 of these are in force and held by Otsuka Pharmaceutical Co., Ltd..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.